Optimizing Adequacy of Bowel Cleansing for Colonoscopy - Recommendations From the US Multi-Society Task Force on Colorectal Cancer

Sep 27, 2026

Uploaded by Himbo

Colorectal cancer (CRC) remains a major cause of cancer-related death in the United States, and colonoscopy helps prevent CRC by detecting and removing precancerous lesions. Because colonoscopy success depends strongly on the adequacy of preprocedure bowel cleansing, inadequate preparation affects outcomes such as adenoma detection, procedural efficiency, cecal intubation, electrocautery risk, and follow-up intervals. The guideline provides expert, evidence-based recommendations to optimize preparation quality and patient safety, prioritizing cleansing efficacy over tolerability when choosing regimens. Recommendations use the GRADE framework to balance strength and evidence quality.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages4

Reading Time10 min

AccessFree to download

Abstract

Effect of Inadequate Preparation on Polyp/Adenoma Detection and Recommended Follow-up Intervals

Recommendations

Dosing and Timing of Colon Cleansing Regimens

Recommendations

Diet During Bowel Cleansing

Recommendation

Usefulness of Patient Education and Navigators for Optimizing Preparation Results

Recommendations

Optimizing Adequacy of Bowel Cleansing for Colonoscopy: Recommendations From the US Multi-Society Task Force on Colorectal Cancer David A. Johnson1, Alan N. Barkun2, Larry B. Cohen3, Jason A. Dominitz4, Tonya Kaltenbach5, Myriam Martel2, Douglas J. Robertson6, 7, C. Richard Boland8, Frances M. Giardello9, David A. Lieberman10, Theodore R. Levin11 and Douglas K. Rex12 1 Eastern VA Medical School, Norfolk, Virginia, USA; 2 McGill University Health Center, McGill University, Montreal, Canada; 3 Icahn School of Medicine at Mount Sinai, New York, New York, USA; 4VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA; 5Veterans Affairs Palo Alto, Stanford University School of Medicine, Palo Alto, California; 6VA Medical Center, USA; 7Geisel School of Medicine at Dartmouth, White River Junction, Vermont, USA; 8 Baylor University Medical Center, Dallas, Texas, USA; 9Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; 10Oregon Health and Science University, Portland, Oregon, USA; 11 Kaiser Permanente Medical Center, Walnut Creek, California, USA; 12 Indiana University School of Medicine, Indianapolis, Indiana, USA. Am J Gastroenterol advance online publication, 16 September 2014; doi:10 . 1038/ajg.2014.272 Abstract Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States (1) . Colonoscopy can prevent CRC by the detection and removal of precancerous lesions. In addition to CRC screening and surveillance, colonoscopy is used widely for the diagnostic evaluation of symptoms and other positive CRC screening tests. Regardless of indication, the success of colonoscopy is linked closely to the adequacy of preprocedure bowel cleansing. Unfortunately, up to 20–25% of all colonoscopies are reported to have an inadequate bowel preparation (2,3) . The reasons for this range from patient-related variables such as compliance with preparation instructions and a variety of medical conditions that make bowel cleansing more difficult to unit-specific factors (eg, extended wait times after scheduling of colonoscopy) (4) . Adverse consequences of ineffective bowel preparation include lower adenoma detection rates, longer procedural time, lower cecal intubation rates, increased electrocautery risk, and shorter intervals between examinations (3,5–7) . Bowel preparation formulations intended for precolonoscopy cleansing are assessed based on their efficacy, safety, and tolerability. Lack of specific organ toxicity is considered to be a prerequisite for bowel preparations. Between cleansing efficacy and tolerability, however, the consequences of inadequate cleansing suggest that efficacy should be a higher priority than tolerability. Consequently, the choice of a bowel cleansing regimen should be based on cleansing efficacy first and patient tolerability second. However, efficacy and tolerability are closely interrelated. For example, a cleansing agent that is poorly tolerated and thus not fully ingested may not achieve an adequate cleansing. The goals of this consensus document are to provide expert, evidence-based recommendations for clinicians to optimize colonoscopy preparation quality and patient safety. Recommendations are provided using the Grades of Recommendation Assessment, Development and Evaluation (GRADE) scoring system, which weighs the strength of the recommendation and the quality of the evidence (8) . Effect of Inadequate Preparation on Polyp/Adenoma Detection and Recommended Follow-up Intervals Recommendations 1. Preliminary assessment of preparation quality should be made in the rectosigmoid colon, and if the indication is screening or surveillance and the preparation clearly is inadequate to allow polyp detection greater than 5 mm, the procedure should be either terminated and rescheduled or an attempt should be made at additional bowel cleansing strategies that can be delivered without cancelling the procedure that day (Strong

FAQs

Why is adequate bowel cleansing important for colonoscopy?

Adequate bowel cleansing improves colonoscopy success, because ineffective preparation is linked to lower adenoma detection, longer procedures, lower cecal intubation rates, increased electrocautery risk, and shorter intervals between examinations.

What should be done if rectosigmoid preparation is clearly inadequate for screening or surveillance?

Preliminary assessment should be made in the rectosigmoid colon. If the preparation cannot allow detection of polyps greater than 5 mm, the procedure should be terminated and rescheduled or additional bowel cleansing strategies should be attempted without canceling that day’s procedure.

Which bowel cleansing approach is strongly recommended for elective colonoscopy?

A split-dose bowel cleansing regimen is strongly recommended for elective colonoscopy, with the second dose ideally starting 4–6 hours before colonoscopy and the last dose completed at least 2 hours before the procedure.

Sep 27, 2026

Uploaded by Himbo